MedTech's Sustainability Dilemma: Reprocessing, Risk, and the Future of Single-Use Devices

This episode explores the growing tension between single-use medical devices and the push for sustainability. We delve into the complex world of reprocessing, examining the regulatory hurdles, validation requirements, and critical liability shifts under frameworks like the US FDA and the EU's Medical Device Regulation (MDR). We discuss how this trend impacts manufacturers, from Instructions for Use (IFU) to risk management, and what the future holds as the circular economy reshapes MedTech business models. Key Questions: - When is a single-use device no longer single-use? - Who becomes the legal manufacturer when a device is reprocessed? - What are the FDA and EU MDR requirements for device reprocessing? - How does reprocessing impact liability for the original manufacturer? - Why do Instructions for Use (IFU) need to be crystal clear about single-use claims? - What validation is needed to prove a reprocessed device is safe and effective? - How is the push for a circular economy changing medical device design and business strategy? - What new risks must be considered when reprocessing a medical device? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, streamlining global market access with local expertise and advanced AI. Whether you're developing a regulatory strategy, compiling a technical dossier, or navigating post-market surveillance, our team can help. We act as your local representative in over 30 markets, using technology to accelerate approvals and ensure compliance. To access global markets faster and more efficiently, contact us at [email protected], visit https://pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai.